|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Kansas Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing KansasLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Aratana Therapeutics, Inc.
| | | Phone: | (844) 272-8262 | Fax: | (913) 904-9641 | Year Established: | 2010 | Ticker: | PETX | Exchange: | NASDAQ | Main Contact: | Steven St. Peter, CEO, President & Founder | | Other Contacts: | Brent A. Standridge, COO John Ayres, General Counsel Erwin Blomsma, PhD, M.Che., General Manager Europe Julia Stephanus, CCO Linda Rhodes, VMD, PhD, CSO Craig Tooman, MBA, CFO Ernst Heinen, DVM, PhD, Chief Development Officer
| | Company Description | Aratana Therapeutics is a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for cats, dogs and other companion animals. Aratana believes that it can leverage the investment in the human biopharmaceutical industry to bring therapeutics to pets in a capital and time efficient manner. The company's pipeline includes more than fifteen therapeutic candidates targeting pain, inappetence, cancer, viral diseases, allergy and other serious medical conditions. Aratana believes the development and commercialization of these therapeutics will permit veterinarians and pet owners to manage pets' medical needs safely and effectively, resulting in longer and improved quality of life for pets. | |
|
|
|
|
|